XYOSTED (AUTOINJECTOR) (testosterone enanthate) by Antares Therapeutics is clinical pharmacology endogenous androgens are responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. First approved in 2018.
Drug data last refreshed 7h ago · AI intelligence enriched 4d ago
XYOSTED is a subcutaneous autoinjector formulation of testosterone enanthate approved in 2018 for testosterone replacement therapy in men with hypogonadism. The drug works by replacing deficient endogenous androgens to restore secondary sex characteristics, muscle mass, bone density, and red blood cell production. Testosterone enanthate is slowly absorbed from the subcutaneous depot, allowing dosing intervals of 2-4 weeks with sustained therapeutic levels.
Product is in peak commercial phase with moderate team investment; growth trajectory dependent on HCP adoption and market penetration in the testosterone replacement segment.
CLINICAL PHARMACOLOGY Endogenous androgens are responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include growth and maturation of prostate, seminal vesicles, penis, and scrotum; development of male hair…
Worked on XYOSTED (AUTOINJECTOR) at Antares Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism
Pharmacokinetic Study of Subcutaneous Testosterone Enanthate
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
Pharmacokinetic Study of Testosterone Enanthate
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moXYOSTED career opportunities are concentrated in senior R&D and finance roles at Antares Therapeutics, reflecting the product's mature, optimized formulation stage and established commercial performance. Positions on this product suit professionals with hormone replacement expertise, formulation science, or strategic commercial analysis experience.
4 open roles linked to this drug